To study the ability of the aIL-15 antibody to prevent IFN-γ production in the epithelium of untreated CeD mucosa, duodenal biopsies from untreated CeD patients were cultured ex vivo with or without the IL-15 neutralizing antibody. The gene discussed is IFNG; the disease is cranioectodermal dysplasia.